id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0266-0006,FDA,FDA-2008-E-0266,Determination of Regulatory Review Period for Purposes of Patent Extension: DORIBAX,Notice,N-Notice,2009-09-04T04:00:00Z,2009,9,2009-09-04T04:00:00Z,2009-11-04T04:59:59Z,2009-09-04T15:33:17Z,E9-21365,0,0,0900006480a1d3ad
FDA-2008-E-0266-0005,FDA,FDA-2008-E-0266,Letter from FDA/CDER to the U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-08-19T04:00:00Z,2009,8,2009-08-19T04:00:00Z,,2009-08-19T19:09:54Z,,0,0,0900006480a0da2b
FDA-2008-E-0266-0004,FDA,FDA-2008-E-0266,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2009-03-31T04:00:00Z,2009,3,2009-03-31T04:00:00Z,,2009-03-31T21:40:39Z,,0,0,0900006480939fc4
FDA-2008-E-0266-0001,FDA,FDA-2008-E-0266,Johnson & Johnson - Patent Term Extension Application,Other,APP-Application,2009-02-27T05:00:00Z,2009,2,2009-02-27T05:00:00Z,,2013-08-11T02:43:09Z,,0,0,090000648053a4d0
FDA-2008-E-0266-0002,FDA,FDA-2008-E-0266,USPTO to FDA/CDER - Letter,Other,LET-Letter,2009-02-27T05:00:00Z,2009,2,2009-02-27T05:00:00Z,,2009-02-27T19:55:04Z,,0,0,090000648053a56b
FDA-2008-E-0266-0003,FDA,FDA-2008-E-0266,Letter to FDA/CDER to the U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-02-27T05:00:00Z,2009,2,2009-02-27T05:00:00Z,,2009-02-27T19:55:05Z,,0,0,09000064808e26df